Literature DB >> 3011500

Characterization of new gangliosides of the lactotetraose series in murine xenografts of a human glioma cell line.

J E Månsson, P Fredman, D D Bigner, K Molin, B Rosengren, H S Friedman, L Svennerholm.   

Abstract

The major mono- and disialogangliosides of the extensively characterized established human glioma line D54MG were isolated and purified from subcutaneous solid xenografts grown in athymic (nu/nu) mice. Structural determination showed that they belonged to the lactotetraosylceramide series. The sialyllactotetraosylceramide contained 90% N-glycolyl- and 10% N-acetylneuraminic acid linked in an alpha 2-3 linkage (IV3NeuGc-LcOse4Cer, IV3NeuAc-LcOse4Cer). The disialogangliosides had a previously undescribed type of structure with sialic acids linked to the terminal galactose in an alpha 2-3 linkage and to N-acetylglucosamine in an alpha 2-6 linkage. Not only did species with NeuAc or NeuGc occur, but also species with mixtures of the two sialic acids, e.g. NeuAc and NeuGc. The schematic structures of the new disialogangliosides are (Formula:see text).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011500     DOI: 10.1016/0014-5793(86)80580-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Matrix-assisted laser desorption ionization time-of-flight mass spectrometry of underivatized and permethylated gangliosides.

Authors:  P Juhasz; C E Costello
Journal:  J Am Soc Mass Spectrom       Date:  1992-11       Impact factor: 3.109

2.  In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line.

Authors:  P Fredman; C J Wikstrand; J E Månsson; G Reifenberger; S H Bigner; A Rasheed; L Svennerholm; D D Bigner
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

3.  Structural characterization of the GM1 ganglioside by infrared multiphoton dissociation, electron capture dissociation, and electron detachment dissociation electrospray ionization FT-ICR MS/MS.

Authors:  Melinda A McFarland; Alan G Marshall; Christopher L Hendrickson; Carol L Nilsson; Pam Fredman; Jan-Eric Månsson
Journal:  J Am Soc Mass Spectrom       Date:  2005-05       Impact factor: 3.109

4.  Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro.

Authors:  K M Hedberg; B Dellheden; C J Wikstrand; P Fredman
Journal:  Glycoconj J       Date:  2000-10       Impact factor: 2.916

5.  Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers.

Authors:  Yi-Wei Lou; Pao-Yuan Wang; Shih-Chi Yeh; Po-Kai Chuang; Shiou-Ting Li; Chung-Yi Wu; Kay-Hooi Khoo; Michael Hsiao; Tsui-Ling Hsu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

6.  Expression of the GM1-species, [NeuN]-GM1, in a case of human glioma.

Authors:  P Fredman; J E Månsson; B Dellheden; K Boström; H von Holst
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

7.  A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth.

Authors:  Merete Thune Wiiger; Hege B Gehrken; Øystein Fodstad; Gunhild M Maelandsmo; Yvonne Andersson
Journal:  Cancer Immunol Immunother       Date:  2010-07-16       Impact factor: 6.968

8.  GMab-1, a high-affinity anti-3'-isoLM1/3',6'-isoLD1 IgG monoclonal antibody, raised in lacto-series ganglioside-defective knockout mice.

Authors:  Yukinari Kato; Chien-Tsun Kuan; Jinli Chang; Mika Kato Kaneko; Joanne Ayriss; Hailan Piao; Vidyalakshmi Chandramohan; Charles Pegram; Roger E McLendon; Pam Fredman; Jan-Eric Månsson; Darell D Bigner
Journal:  Biochem Biophys Res Commun       Date:  2009-11-26       Impact factor: 3.575

9.  Ganglioside mapping of a human medulloblastoma xenograft.

Authors:  J Gottfries; J E Mansson; P Fredman; C J Wikstrand; H S Friedman; D D Bigner; L Svennerholm
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 10.  Medulloblastoma: tumor biological and clinical perspectives.

Authors:  H S Friedman; W J Oakes; S H Bigner; C J Wikstrand; D D Bigner
Journal:  J Neurooncol       Date:  1991-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.